HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N P Restifo Selected Research

Chemokines

4/2000Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N P Restifo Research Topics

Disease

19Neoplasms (Cancer)
10/2015 - 01/2000
9Melanoma (Melanoma, Malignant)
11/2008 - 01/2000
3Experimental Melanoma
05/2013 - 08/2001
3Communicable Diseases (Infectious Diseases)
10/2000 - 01/2000
3Vitiligo
04/2000 - 01/2000
2Vaccinia
11/2001 - 04/2000
1Prader-Willi Syndrome (Syndrome, Prader-Willi)
11/2001
1Neoplasm Metastasis (Metastasis)
11/2001
1Colorectal Neoplasms (Colorectal Cancer)
11/2001
1Inflammation (Inflammations)
10/2000
1Virus Diseases (Viral Diseases)
10/2000
1Prostatic Neoplasms (Prostate Cancer)
04/2000
1Renal Cell Carcinoma (Grawitz Tumor)
02/2000

Drug/Important Bio-Agent (IBA)

9AntigensIBA
05/2013 - 01/2000
7Peptides (Polypeptides)IBA
11/2008 - 01/2000
7VaccinesIBA
11/2001 - 02/2000
5Neoplasm Antigens (Tumor Antigens)IBA
05/2013 - 04/2000
5Proteins (Proteins, Gene)FDA Link
11/2001 - 01/2000
4CytokinesIBA
05/2013 - 04/2000
4Differentiation AntigensIBA
11/2008 - 01/2000
3EpitopesIBA
05/2000 - 01/2000
3DNA (Deoxyribonucleic Acid)IBA
02/2000 - 01/2000
2Cancer VaccinesIBA
11/2001 - 02/2000
2AutoantigensIBA
05/2000 - 01/2000
2Monophenol Monooxygenase (Tyrosinase)IBA
04/2000 - 01/2000
2Synthetic Vaccines (Recombinant Vaccines)IBA
02/2000 - 01/2000
1Biological ProductsIBA
05/2013
1Transforming Growth Factors (Transforming Growth Factor)IBA
05/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2008
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2001
1P.polypeptideIBA
11/2001
1CD40 Ligand (CD40L)IBA
11/2001
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
08/2001
1Monoclonal AntibodiesIBA
08/2001
1Double-Stranded RNA (RNA, Double Stranded)IBA
10/2000
1Antiviral Agents (Antivirals)IBA
10/2000
1Protein Kinases (Protein Kinase)IBA
10/2000
1NexusIBA
10/2000
1CaspasesIBA
10/2000
1Interleukin-18 (Interleukin 18)IBA
10/2000
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
07/2000
1HLA-DR4 Antigen (HLA DR4 Antigen)IBA
07/2000
1Amino AcidsFDA Link
05/2000
1Histocompatibility Antigens Class IIBA
05/2000
1DNA VaccinesIBA
05/2000
1UbiquitinIBA
05/2000
1HLA-A*02:01 antigenIBA
04/2000
1ChemokinesIBA
04/2000
1beta-Galactosidase (Lactaid)IBA
04/2000
1HLA-DRB1*04:01 antigenIBA
04/2000
1EndostatinsIBA
03/2000
1Interleukin-2 (IL2)IBA
02/2000
1Protein Subunit VaccinesIBA
02/2000
1InterleukinsIBA
02/2000
1Nucleic Acid-Based VaccinesIBA
01/2000
1Histocompatibility Antigens Class IIIBA
01/2000

Therapy/Procedure

7Immunotherapy
10/2015 - 01/2000
2Therapeutics
08/2001 - 04/2000
1Ligation
10/2000